Insider · CIK 0001328288

Gergel Ivan P.

Reports to the SEC for 7 companies · CHADDS FORD, PA

sec.gov

Transactions

Companies

Filings

CIK

0001328288

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2020-12-01	Neurotrope, Inc.Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−10K sh	—	—	0
2020-12-01	Neurotrope, Inc.Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−7,813 sh	—	—	0
2020-12-01	Neurotrope, Inc.Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−10K sh	—	—	0
2020-12-01	Neurotrope, Inc.Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−10K sh	—	—	0
2020-12-01	Neurotrope, Inc.Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−15K sh	—	—	0
2020-11-24	Neurotrope, Inc.Stock Option (right to buy)A Award	Director	AAward	+15K sh	—	—	15,000
2020-03-20	Neurotrope, Inc.Stock Option (right to buy)A Award	Director	AAward	+10K sh	—	—	10,000
2019-03-15	Neurotrope, Inc.Stock Option (right to buy)A Award	Director	AAward	+10K sh	—	—	10,000
2019-01-22	Neurotrope, Inc.Stock Option (right to buy)A Award	Director	AAward	+10K sh	—	—	10,000
2018-12-13	Neurotrope, Inc.Stock Option (right to buy)A Award	Director	AAward	+7,813 sh	—	—	7,813
2018-11-27	Corium International, Inc.Director Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−15K sh	$12.50	−$188K	0
2018-11-27	Corium International, Inc.Director Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−12K sh	$12.50	−$150K	0
2018-11-27	Corium International, Inc.Director Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−15K sh	$12.50	−$188K	0
2018-11-27	Corium International, Inc.Director Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−20K sh	$12.50	−$250K	0
2017-12-01	Corium International, Inc.Director Stock Option (Rigth to Buy)A Award	Director	AAward	+15K sh	—	—	15,000
2017-11-16	NKTRNEKTAR THERAPEUTICSD Disposition to Issuer	SVP & Chief Medical Officer	DDisposition to Issuer	−5,022 sh	$44.23	−$222K	56,553
2017-11-15	NKTRNEKTAR THERAPEUTICS · Stock OptionA Award	SVP & Chief Medical Officer	AAward	+50K sh	—	—	50,000
2017-11-15	NKTRNEKTAR THERAPEUTICSA Award	SVP & Chief Medical Officer	AAward	+20K sh	—	—	61,575
2017-10-02	NKTRNEKTAR THERAPEUTICSS Sale	SVP & Chief Medical Officer	SSale	−56.7K sh	$24.21	−$1.37M	41,575
2017-10-02	NKTRNEKTAR THERAPEUTICS · Stock OptionM Exercise/Conversion	SVP & Chief Medical Officer	MExercise/Conversion	−56.7K sh	—	—	313,752
2017-10-02	NKTRNEKTAR THERAPEUTICSM Exercise/Conversion	SVP & Chief Medical Officer	MExercise/Conversion	+56.7K sh	$11.04	+$626K	98,279
2017-09-29	NKTRNEKTAR THERAPEUTICS · Stock OptionM Exercise/Conversion	SVP & Chief Medical Officer	MExercise/Conversion	−43.3K sh	—	—	370,456
2017-09-29	NKTRNEKTAR THERAPEUTICSS Sale	SVP & Chief Medical Officer	SSale	−43.3K sh	$24.04	−$1.04M	41,575
2017-09-29	NKTRNEKTAR THERAPEUTICSM Exercise/Conversion	SVP & Chief Medical Officer	MExercise/Conversion	+43.3K sh	$11.04	+$478K	84,871
2017-08-16	NKTRNEKTAR THERAPEUTICSS Sale	SVP & Chief Medical Officer	SSale	−1,997 sh	$19.32	−$38.6K	41,575
2017-07-18	NKTRNEKTAR THERAPEUTICS · Stock OptionM Exercise/Conversion	SVP & Chief Medical Officer	MExercise/Conversion	−54.9K sh	—	—	413,752
2017-07-18	NKTRNEKTAR THERAPEUTICSS Sale	SVP & Chief Medical Officer	SSale	−54.9K sh	$21.10	−$1.16M	43,572
2017-07-18	NKTRNEKTAR THERAPEUTICSM Exercise/Conversion	SVP & Chief Medical Officer	MExercise/Conversion	+54.9K sh	$11.04	+$606K	98,492
2017-07-12	NKTRNEKTAR THERAPEUTICSM Exercise/Conversion	SVP & Chief Medical Officer	MExercise/Conversion	+36.7K sh	$11.04	+$405K	80,263
2017-07-12	NKTRNEKTAR THERAPEUTICS · Stock OptionM Exercise/Conversion	SVP & Chief Medical Officer	MExercise/Conversion	−36.7K sh	—	—	468,672
2017-07-12	NKTRNEKTAR THERAPEUTICSS Sale	SVP & Chief Medical Officer	SSale	−36.7K sh	$21.09	−$774K	43,572
2017-07-11	NKTRNEKTAR THERAPEUTICSS Sale	SVP & Chief Medical Officer	SSale	−8,389 sh	$21.04	−$177K	43,572
2017-07-11	NKTRNEKTAR THERAPEUTICSM Exercise/Conversion	SVP & Chief Medical Officer	MExercise/Conversion	+8,389 sh	$11.04	+$92.6K	51,961
2017-07-11	NKTRNEKTAR THERAPEUTICS · Stock OptionM Exercise/Conversion	SVP & Chief Medical Officer	MExercise/Conversion	−8,389 sh	—	—	505,363
2017-05-16	NKTRNEKTAR THERAPEUTICSS Sale	SVP & Chief Medical Officer	SSale	−1,450 sh	$19.55	−$28.3K	43,572
2017-02-16	NKTRNEKTAR THERAPEUTICSS Sale	SVP & Chief Medical Officer	SSale	−1,457 sh	$13.14	−$19.1K	45,022
2016-12-22	Corium International, Inc.Director Stock Option (Right to Buy)A Award	Director	AAward	+15K sh	—	—	15,000
2016-12-13	NKTRNEKTAR THERAPEUTICS · Stock OptionA Award	SVP & Chief Medical Officer	AAward	+50K sh	—	—	50,000
2016-12-13	NKTRNEKTAR THERAPEUTICSA Award	SVP & Chief Medical Officer	AAward	+20K sh	—	—	46,479
2016-11-16	NKTRNEKTAR THERAPEUTICSS Sale	SVP & Chief Medical Officer	SSale	−848 sh	$13.96	−$11.8K	26,479
2016-08-16	NKTRNEKTAR THERAPEUTICSS Sale	SVP & Chief Medical Officer	SSale	−1,685 sh	$17.56	−$29.6K	27,327
2016-07-14	NKTRNEKTAR THERAPEUTICS · Stock OptionA Award	SVP & Chief Medical Officer	AAward	+50K sh	—	—	50,000
2016-07-14	NKTRNEKTAR THERAPEUTICSA Award	SVP & Chief Medical Officer	AAward	+15K sh	—	—	16,521
2016-07-14	NKTRNEKTAR THERAPEUTICS · Stock OptionA Award	SVP & Chief Medical Officer	AAward	+12.5K sh	—	—	12,500
2016-05-17	NKTRNEKTAR THERAPEUTICSS Sale	SVP & Chief Medical Officer	SSale	−432 sh	$13.58	−$5,866.56	1,512
2016-05-16	NKTRNEKTAR THERAPEUTICSM Exercise/Conversion	SVP & Chief Medical Officer	MExercise/Conversion	+1,250 sh	$0.00	+$0.125	1,944
2016-05-16	NKTRNEKTAR THERAPEUTICS · Restricted Stock UnitD Disposition to Issuer	SVP & Chief Medical Officer	DDisposition to Issuer	−1,250 sh	—	—	12,500
2016-02-17	NKTRNEKTAR THERAPEUTICSS Sale	SVP & Chief Medical Officer	SSale	−556 sh	$11.92	−$6,627.52	694
2016-02-16	NKTRNEKTAR THERAPEUTICS · Restricted Stock UnitD Disposition to Issuer	SVP & Chief Medical Officer	DDisposition to Issuer	−1,250 sh	—	—	13,750
2016-02-16	NKTRNEKTAR THERAPEUTICSM Exercise/Conversion	SVP & Chief Medical Officer	MExercise/Conversion	+1,250 sh	$0.00	+$0.125	1,250

Recent filings

Accepted (ET)
Dec 34
Gergel Ivan P.0001104659-20-132157
SEC(opens sec.gov)
Nov 274
Gergel Ivan P.0001104659-20-130084
SEC(opens sec.gov)
Mar 244
Gergel Ivan P.0001104659-20-037868
SEC(opens sec.gov)
Apr 154
Gergel Ivan P.0001144204-19-019707
SEC(opens sec.gov)
Jan 244
Gergel Ivan P.0001144204-19-002691
SEC(opens sec.gov)
Dec 174
Gergel Ivan P.0001144204-18-064949
SEC(opens sec.gov)
Nov 284
Gergel Ivan P.0001567619-18-007067
SEC(opens sec.gov)
Dec 54
Gergel Ivan P.0001140361-17-045106
SEC(opens sec.gov)
Nov 174
Gergel Ivan P.0001209191-17-061590
SEC(opens sec.gov)
Oct 34
Gergel Ivan P.0001209191-17-055353
SEC(opens sec.gov)

Companies

Address

C/O ENDO PHARMACEUTICALS HOLDINGS INC. 100 ENDO BOULEVARD

CHADDS FORD, PA, 19317